These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26547261)

  • 21. Liquid chromatography tandem mass spectrometric studies of indinavir sulphate and its forced degradation products.
    Rao RN; Vali RM; Raju SS
    J Pharm Biomed Anal; 2013 Feb; 74():101-10. PubMed ID: 23245240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
    Tiwari RN; Bonde CG
    J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MS/MS characterization of forced degradation products of zofenopril.
    Ramesh T; Nageswara Rao P; Nageswara Rao R
    J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of degradation products of idarubicin through LC-UV, MS(n) and LC-MS-TOF studies.
    Kaushik D; Bansal G
    J Pharm Biomed Anal; 2013 Nov; 85():123-31. PubMed ID: 23933565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.
    Mahadik M; Bhusari V; Kulkarni M; Dhaneshwar S
    J Pharm Biomed Anal; 2009 Dec; 50(5):787-93. PubMed ID: 19615841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
    Kalariya PD; Talluri MV; Patel PN; Srinivas R
    J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
    Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
    Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.
    Bansal G; Maddhesia PK; Bansal Y
    Analyst; 2011 Dec; 136(24):5218-28. PubMed ID: 22013582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural identification of degradants of moexipril by LC-MS/MS.
    Challa PR; K R; K M V NR
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LC-MS/MS structural characterization of stress degradation products including the development of a stability indicating assay of Darunavir: An anti-HIV drug.
    Rao RN; Ramachandra B; Sravan B; Khalid S
    J Pharm Biomed Anal; 2014 Feb; 89():28-33. PubMed ID: 24252722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of degradation products of irbesartan using LC-MS/TOF, MS(n), on-line H/D exchange and LC-NMR.
    Shah RP; Sahu A; Singh S
    J Pharm Biomed Anal; 2010 Apr; 51(5):1037-46. PubMed ID: 20018473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forced degradation, LC-UV, MS(n) and LC-MS-TOF studies on azilsartan: Identification of a known and three new degradation impurities.
    Kaushik D; Kaur J; Paul Kaur V; Saini B; Bansal Y; Bansal G
    J Pharm Biomed Anal; 2016 Feb; 120():202-11. PubMed ID: 26752083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
    Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid chromatography electrospray ionization tandem mass spectrometry study of nilutamide and its stress degradation products: in silico toxicity prediction of degradation products.
    Ramesh Babu A; Borkar RM; Raju G; Raju B; Srinivas R
    Biomed Chromatogr; 2014 Jun; 28(6):788-93. PubMed ID: 24861745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS.
    Wu C; Xu X; Feng C; Shi Y; Liu W; Zhu X; Zhang J
    J Pharm Biomed Anal; 2014 Sep; 98():356-63. PubMed ID: 24992215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LC, MS
    Tiwari RN; Shah N; Bhalani V; Mahajan A
    J Pharm Anal; 2015 Feb; 5(1):33-42. PubMed ID: 29403913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.